Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS; A Randomized Controlled Open-Label Pilot Study

NCT06452511 is registered in ClinicalTrials.gov with Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy as lead sponsor.

NCT NCT06452511
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06452511 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Comparing the Effect of Metformin vs. Pep2dia as an Adjunct to Letrozole on Ovulation Induction and Pregnancy Outcomes in Overweight Women With PCOS; A Randomized Controlled Open-Label Pilot Study
Lead sponsor
Muhamed Ahmed Abdelmoaty Muhamed Alhagrasy
Phase
Phase 1
Overall status
Completed
Start date
August 1, 2024
Completion date
March 25, 2025
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pcos